Accueil > Revues > Médecine > European Journal of Dermatology > Texte intégral de l'article
 
      Recherche avancée    Panier    English version 
 
Nouveautés
Catalogue/Recherche
Collections
Toutes les revues
Médecine
European Journal of Dermatology
- Numéro en cours
- Archives
- S'abonner
- Commander un       numéro
- Plus d'infos
Biologie et recherche
Santé publique
Agronomie et Biotech.
Mon compte
Mot de passe oublié ?
Activer mon compte
S'abonner
Licences IP
- Mode d'emploi
- Demande de devis
- Contrat de licence
Commander un numéro
Articles à la carte
Newsletters
Publier chez JLE
Revues
Ouvrages
Espace annonceurs
Droits étrangers
Diffuseurs



 

Texte intégral de l'article
 
  Version imprimable

Type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematised pattern of involvement and pronounced cancer proneness


European Journal of Dermatology. Volume 11, Numéro 3, 191-4, May - June 2001, Gènes et peau


Summary  

Auteur(s) : Y. Murata, K. Kumano, T. Takai, Department of Dermatology, Hyogo Medical Center for Adults, 13-70, Kitaojicho, Akashi, 673-8558, Japan..

Illustrations

ARTICLE

Porokeratosis is a genetically determined skin disorder characterized by circular lesions with distinct peripheral ridges that histopathologically correspond to a parakeratotic column. Among the different types of porokeratosis, linear porokeratosis is rare and distinct because of the characteristic linear distribution of the lesions and increased susceptibility to malignant transformation [1]. Here, we report a case of linear porokeratosis that developed multiple squamous cell carcinomas.

Case report

A 61-year-old Japanese woman had first noticed in her early teens brown eruptions on the left side of the trunk. They increased in number gradually and developed on torso and extremities, mainly on the left side. One year prior to her first visit, an ulcerating tumor developed on the left elbow, which became larger and painful.

On physical examination, an ulcerating tumor measuring 5 cm in diameter was seen in the left cubital fossa (Fig. 1). The ulcer was covered with necrotic or keratotic material, and the margin was elevated. Physical examination also exhibited many round dark brown macules with peripheral keratotic ridges up to 1 to 2 cm in diameter. Most of these were distributed on the left side of the body, while a small number of similar but smaller and lighter-colored lesions were noted, scattered on the right side of the body (Fig. 2).

The lesions on the left side of the body were arranged in a linear pattern running from the dorsal aspect to the ventral aspect obliquely on her shoulder, lateral chest wall, abdominal wall. On the center of the lower abdomen, they were arranged in a vertical longitudinal line. On the left extremities, a linear to oblique pattern was noted. This pattern of distribution of the lesions was consistent with Blaschko's lines. The ulcerating tumor was located within a streak of porokeratotic lesions on the left cubitus.

Under general anesthesia, the tumor of the left cubitus was resected and the skin defect was covered with a skin graft. Histopathologically the tumor was diagnosed as a well-differentiated squamous cell carcinoma with invasive growth of atypical keratinocytes into the whole dermis and upper part of subcutaneous tissue (Fig. 3). The hyperpigmented annular lesions showed typical histopathologic features of porokeratosis, namely an invagination of the epidermis containing a cornoid lamella (Fig. 4). Immuno-histochemical studies disclosed an increased p53 expression within the tumor cells, but not within the keratinocytes underlying the cornoid lamella.

She was noted to have 4 additional lesions of early but invasive squamous cell carcinomas on her left buttock, left thigh, left waist and left hip. All of them were located within the linear areas of pronounced porokeratotic lesions. These tumors were resected. Ten years later, she came back to us because of ulcerating tumors on her left shoulder, left elbow and left thigh. These tumors were resected and diagnosed histopathologically as moderately to well differentiated squamous cell carcinomas. No metastasis to lymphnodes or distant organs has been noted so far.

She had had tuberculosis at the age of 16 and had undergone left mammectomy because of breast cancer when she was 44 years old. Her elder brother, 72 years old, had widely distributed disseminated superficial porokeratosis (Fig. 5) and liver cirrhosis. He had been an out-door worker and extensive exposure to sunlight was supposed. His daughter, 38 years old, had a small number of scattered porokeratotic lesions. These family members were shown both clinically and histopathologically to have disseminated superficial porokeratosis. Skin tumors or any linear distribution of porokeratotic lesions were not seen. They claimed that some of their family members had similar cutaneous lesions (Fig. 6).

Discussion

The segmental distribution of the skin lesions in this case can be best explained by an early postzygotic mutation in addition to a mutation of the other allele, the latter being also present in several other family members. There are several pieces of evidence that support this concept of pathogenesis. First, her family tree shows that the mode of inheritance is autosomal dominant. Second, several other family members had disseminated superficial porokeratosis but not linear porokeratosis. Third, the right side of the patient's body showed mild involvement in the form of disseminated superficial porokeratosis, namely, sparsely distributed, small and light-colored non-linear lesions. Fourth, the segmental involvement on the left side of the body was distributed along Blaschko's lines, and showed a far more pronounced degree of severity in color and size than on the right side of the body. Thus, this case could be best explained by an early postzygotic mutational event giving rise to loss of heterozygosity at the locus responsible for the porokeratotic trait and resulting in a type 2 segmental manifestation of disseminated superficial porokeratosis showing a systematized pattern of involvement [2-4].

Furthermore, the present case showed the development of 9 squamous cell carcinomas. All of these tumors arose within the segmental lesions on the left side of the body and not on the right side of the body where only smaller and lighter-colored lesions were sparsely distributed. It is known that skin cancers may develop on the lesions of porokeratosis, particularly in the linear type [5]. This case may be a good example of the high proneness to malignant degeneration of linear porokeratosis. Happle suggested that prenatal loss of heterozygosity may represent an initial step in the development of cancer on linear porokeratosis [4].

Nelson et al. [6] demonstrated immunohistochemically an increased p53 expression within keratinocytes underlying the cornoid lamella, suggesting the role of p53 in the pathogenesis of the porokeratoses. In the present case, immunohistochemical studies demonstrated an increased p53 expression within the atypical keratinocytes constituting the carcinomatous lesions, but no over-expression of p53 was demonstrated within keratinocytes underlying the cornoid lamella. Anzai et al. studied a similar case of squamous cell carinoma and linear porokeratosis, and they reported that p53 over-expression was observed in the tumor cells, but not in the porokeratotic lesions [7]. Recently, Xia et al. identified a locus at chromosome 12q23.2-24.1. responsible for disseminated superficial actinic porokeratosis [8]. The gene coding p53 maps on 17p13.1 [9] distinct from that mentioned by Xia et al.

Further investigation is needed to elucidate the pathogenesis of linear porokeratosis and the mechanism of development of malignant lesions from porokeratosis..

Article accepted on 5/3/01

REFERENCES

1. Atherton DJ. Linear porokeratosis. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds, Textbook of Dermatology, 6th edition. Oxford: Blackwell Science, 1998: 527-8.

2. Freyschmidt-Paul P, Hoffmann R, Koenig A, Happle R. Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: report of two cases exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders. J Am Acad Dermatol 1999; 41: 644-7.

3. Happle R. Somatic recombination may explain linear porokeratosis associated with disseminated superficial actinic porokeratosis. Am J Med Genet 1991; 39: 237.

4. Happle R. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology 1997; 195: 20-5.

5. Lozinski AZ, Fisher BK, Walter JB, et al. Metastatic squamous cell carcinoma in linear porokeratosis of Mibelli. J Am Acad Dermatol 1987; 16: 448-51.

6. Nelson C, Cowper S, Morgan M. p53, mdm-2, and p21 waf-1 in the porokeratoses. Am J Dermatopathol 1999; 21: 420-5.

7. Anzai S, Takeo N, Yamaguchi T, Sato T, Takasaki S, Terashi H, Takayasu S, Takahashi S. Squamous cell carcinoma in a renal transplant recipient with linear porokeratosis. J Dermatol 1999; 26: 244-7.

8. Xia JH, Yang YF, Deng H, Tang BS, Tang DS, He YG, Xia K, Chen SX, Li YX, Pan Q, Long ZG, Dai HP, Liao XD, Xiao JF, Liu ZR, Lu CY, Yu KP, Deng HX. Identification of a locus for disseminated superficial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol 2000; 114: 1071-4.

9. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutation in the p53 tumor suppressor gene: clue to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-78.


 

Qui sommes-nous ? - Contactez-nous - Conditions d'utilisation - Paiement sécurisé
Actualités - Les congrès
Copyright © 2007 John Libbey Eurotext - Tous droits réservés
[ Informations légales - Powered by Dolomède ]